79 related articles for article (PubMed ID: 32676392)
1. Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
Peng Q; Zhou Y; Jin L; Cao C; Gao C; Zhou J; Yang D; Zhu J
Transl Androl Urol; 2020 Jun; 9(3):1082-1098. PubMed ID: 32676392
[TBL] [Abstract][Full Text] [Related]
2. A novel DNA methylation signature revealed GDF6 and RCC1 as potential prognostic biomarkers correlated with cell proliferation in clear cell renal cell carcinoma.
Xu Z; Wu Y; Zhao G; Jin B; Jiang P
Mol Biol Rep; 2023 Dec; 51(1):16. PubMed ID: 38087057
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
Zhang Z; Lin E; Zhuang H; Xie L; Feng X; Liu J; Yu Y
Cancer Cell Int; 2020; 20():27. PubMed ID: 32002016
[TBL] [Abstract][Full Text] [Related]
4. A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Peng L; Liang J; Wang Q; Chen G
Front Genet; 2022; 13():798846. PubMed ID: 35656315
[No Abstract] [Full Text] [Related]
5. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
Wang YL; Zhang YY
Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling to predict overall survival risk in gastric cancer: development and validation of a nomogram to optimize clinical management.
Ma X; Chen H; Wang G; Li L; Tao K
J Cancer; 2020; 11(15):4352-4365. PubMed ID: 32489454
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
Liu J; Shi Y; Zhang Y
EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
[TBL] [Abstract][Full Text] [Related]
8. A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis-immune-related gene signature.
Ding G; Wang T; Tang G; Zou Q; Wu G; Wu J
Heliyon; 2024 Jan; 10(1):e23503. PubMed ID: 38170124
[TBL] [Abstract][Full Text] [Related]
9. Validation of prognostic signature and exploring the immune-related mechanisms for
Chen D; Yin Z; Chen Y; Bai Y; You B; Sun Y; Wu Y
Transl Cancer Res; 2023 Oct; 12(10):2518-2532. PubMed ID: 37969386
[TBL] [Abstract][Full Text] [Related]
10. Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Lv L; Cao L; Hu G; Shen Q; Wu J
Front Genet; 2020; 11():294. PubMed ID: 32296463
[TBL] [Abstract][Full Text] [Related]
11. FBXL6 depletion restrains clear cell renal cell carcinoma progression.
Yu Y; Yao W; Wang T; Xue W; Meng Y; Cai L; Jian W; Yu Y; Zhang C
Transl Oncol; 2022 Dec; 26():101550. PubMed ID: 36183674
[TBL] [Abstract][Full Text] [Related]
12. Multiomics combined with single-cell analysis shows that mitophagy-related genes could accurately predict the prognosis of patients with clear cell renal cell carcinoma.
Yin H; Xiao Y; Li H; Wang Y; Zhang L; Yao A; Kang S; Cao F
Transl Cancer Res; 2024 Feb; 13(2):819-832. PubMed ID: 38482447
[TBL] [Abstract][Full Text] [Related]
13. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic Accuracy.
Franz A; Ralla B; Weickmann S; Jung M; Rochow H; Stephan C; Erbersdobler A; Kilic E; Fendler A; Jung K
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31575051
[TBL] [Abstract][Full Text] [Related]
15. Leveraging a Genomic Instability-Derived Signature to Predict the Prognosis and Therapy Sensitivity of Clear Cell Renal Cell Carcinoma.
Wei C; Tao T; Zhou J; Zhu X
Clin Genitourin Cancer; 2024 Apr; 22(2):134-148.e8. PubMed ID: 37919101
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review: ClearCode 34 - A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC).
Ghatalia P; Rathmell WK
Kidney Cancer; 2018; 2(1):23-29. PubMed ID: 30320241
[TBL] [Abstract][Full Text] [Related]
17. Construction of methylation driver gene-related prognostic signature and development of a new prognostic stratification strategy in neuroblastoma.
Han Y; Li B; Cheng J; Zhou D; Yuan X; Zhao W; Zhang D; Zhang J
Genes Genomics; 2024 Feb; 46(2):171-185. PubMed ID: 38180715
[TBL] [Abstract][Full Text] [Related]
18. Identifying genes associated with disease outcomes using joint sparse canonical correlation analysis-An application in renal clear cell carcinoma.
Dutta D; Sen A; Satagopan JM
Genet Epidemiol; 2024 May; ():. PubMed ID: 38751238
[TBL] [Abstract][Full Text] [Related]
19. Correction: Clinical findings and a DNA methylation signature in kindreds with alterations in ZNF711.
Wang J; Foroutan A; Richardson E; Skinner SA; Reilly J; Kerkhof J; Curry CJ; Tarpey PS; Robertson SP; Maystadt I; Keren B; Dixon JW; Skinner C; Stapleton R; Ruaud L; Gumus E; Lakeman P; Alders M; Tedder ML; Schwartz CE; Friez MJ; Sadikovic B; Stevenson RE
Eur J Hum Genet; 2023 Dec; ():. PubMed ID: 38040915
[No Abstract] [Full Text] [Related]
20. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
